Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemonucleolysis: an evolving concept and clinical review.

A MacDiarmid, P Welsh

    The Australian and New Zealand Journal of Surgery
    |April 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical utility of liver function tests for resolution of metabolic dysfunction-associated steatotic liver disease after weight loss in the Diabetes Remission Clinical Trial.

    Diabetic medicine : a journal of the British Diabetic Association·2024
    Same author

    GDF15 linked to maternal risk of nausea and vomiting during pregnancy.

    Nature·2023
    Same author

    Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy.

    bioRxiv : the preprint server for biology·2023
    Same author

    Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT).

    Diabetic medicine : a journal of the British Diabetic Association·2020
    Same author

    Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

    QJM : monthly journal of the Association of Physicians·2019
    Same author

    Associations of dietary protein intake with bone mineral density: An observational study in 70,215 UK Biobank participants.

    Bone·2018

    Chemonucleolysis using chymopapain shows promise for lumbar disc disease, especially for sciatica symptoms under 3 months. Careful patient selection is key for successful short-term outcomes.

    Area of Science:

    • Neurosurgery
    • Orthopedic Surgery
    • Pain Management

    Background:

    • Chemonucleolysis, an enzyme-based treatment for lumbar disc disease, has faced clinical debate despite emerging evidence.
    • Chymopapain, the enzyme used, has shown efficacy but its application remains controversial.

    Purpose of the Study:

    • To evaluate the clinical effectiveness of chemonucleolysis in patients with lumbar disc disease unresponsive to conservative treatments.
    • To identify patient characteristics and disease factors influencing chemonucleolysis outcomes.

    Main Methods:

    • A cohort of 84 patients with lumbar disc disease received chymopapain injections over 12 months.
    • Patients were assessed pre-injection and followed up 5-15 months post-injection.
    • Data analysis focused on symptom duration, pain type (sciatica vs. low back pain), and patient demographics.

    Related Experiment Videos

    Main Results:

    • Chemonucleolysis was most effective in patients with classical prolapsed lumbar disc symptoms and sciatica predominant for less than 3 months.
    • Patients with pain exceeding 6 months or predominantly low back pain showed poor results.
    • Workers' compensation patients did not exhibit favorable outcomes.

    Conclusions:

    • Careful patient selection is crucial for achieving good short-term results with chemonucleolysis.
    • Accurate enzyme placement is essential for treatment efficacy.
    • Chemonucleolysis can be a viable option for specific patient profiles with lumbar disc disease.